瑞普生物(300119)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300119 瑞普生物

已收盘 12-26 15:00:00

{"stockData":{"symbol":"300119","market":"SZ","secType":"STK","nameCN":"瑞普生物","latestPrice":19.37,"timestamp":1766732589000,"preClose":19.43,"halted":0,"volume":2944400,"delay":0,"changeRate":-0.0031,"floatShares":335000000,"shares":465000000,"eps":0.9001,"marketStatus":"已收盘","change":-0.06,"latestTime":"12-26 15:00:00","open":19.36,"high":19.47,"low":19.27,"amount":57013500,"amplitude":0.0103,"askPrice":19.37,"askSize":128,"bidPrice":19.36,"bidSize":329,"shortable":0,"etf":0,"ttmEps":0.9001,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":5,"adr":0,"adjPreClose":19.43,"symbolType":"stock","openAndCloseTimeList":[[1766712600000,1766719800000],[1766725200000,1766732400000]],"highLimit":21.37,"lowLimit":17.49,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":464754706,"isCdr":false,"pbRate":1.93,"roa":"--","peRate":21.519831,"roe":"7.93%","epsLYR":0.6533,"committee":0.418142,"marketValue":9002000000,"turnoverRate":0.0088,"status":1,"floatMarketCap":6488000000},"requestUrl":"/m/hq/s/300119","defaultTab":"news","newsList":[{"id":"2593479866","title":"瑞普生物最新公告：公司及下属公司取得两款新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2593479866","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593479866?lang=zh_cn&edition=full","pubTime":"2025-12-24 18:41","pubTimestamp":1766572871,"startTime":"0","endTime":"0","summary":"瑞普生物公告称，公司及下属公司天津瑞普生物技术股份有限公司空港经济区分公司、瑞普（保定）生物药业有限公司近日获农业农村部批准，取得两款新兽药注册证书。其中，猪圆环病毒2型、猪肺炎支原体、副猪嗜血杆菌三联灭活疫苗为国内技术领先的猪用多联多价疫苗，主要用于预防猪圆环病毒2型感染、猪支原体肺炎及副猪嗜血杆菌血清4型、5型感染引起的疾病。两款产品均有助于提升公司在相关领域的市场占有率和业绩增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400031103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0070","300119"],"gpt_icon":0},{"id":"2593146406","title":"瑞普生物：截至2025年12月19日股东总户数2.5万余户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593146406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593146406?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:03","pubTimestamp":1766473394,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至12月20日，公司持股股东人数多少人？谢谢瑞普生物回复：投资者您好，截至2025年12月19日，公司股东总户数2.5万余户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300018751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","BK0239","300119"],"gpt_icon":0},{"id":"2593483287","title":"瑞派宠物医院递表港交所 为中国第二大宠物医疗服务提供商","url":"https://stock-news.laohu8.com/highlight/detail?id=2593483287","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593483287?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:05","pubTimestamp":1766394300,"startTime":"0","endTime":"0","summary":"据港交所12月22日披露，瑞派宠物医院管理股份有限公司(简称：瑞派宠物医院)向港交所主板递交上市申请，中金公司为独家保荐人。公司简介据招股书，该公司是一家全国性连锁宠物医疗机构，致力 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251222/c673401584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["300119","BK0046","BK0070","BK0239"],"gpt_icon":0},{"id":"2591261988","title":"瑞普生物（300119）披露董事会换届选举结果，12月16日股价下跌0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591261988","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591261988?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:54","pubTimestamp":1765878859,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，瑞普生物报收于19.03元，较前一交易日下跌0.78%，最新总市值为88.44亿元。该股当日开盘19.21元，最高19.27元，最低18.98元，成交额达7431.76万元，换手率为1.16%。近日，瑞普生物发布2025年第六次临时股东会决议公告，公司于2025年12月15日召开临时股东会，审议通过董事会换届选举议案，选举李守军、徐雷、刘爱玲、朱秀同、李睿为第六届董事会非独立董事，董义春、王凯、李娅为独立董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600030121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0070","300119"],"gpt_icon":0},{"id":"2590596808","title":"瑞普生物：截至2025年12月10日股东总户数约2.5万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590596808","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590596808?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:45","pubTimestamp":1765442739,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至12月10日，公司持股股东人数多少人？谢谢瑞普生物回复：投资者您好，截至2025年12月10日，公司股东总户数约2.5万户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100025338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300119","BK0070","BK0046"],"gpt_icon":0},{"id":"2590831665","title":"瑞普生物：公司无犬肥大细胞瘤mRNA疫苗产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2590831665","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590831665?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:21","pubTimestamp":1765268475,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)12月09日在投资者关系平台上答复投资者关心的问题。投资者提问：网上流传说：瑞普生物有一款针对犬肥大细胞瘤的MRNA肿瘤疫苗在2024年就已经上市，并于2025年已进入了瑞派、瑞鹏的连锁宠物医院采购体系，这则消息请问是真的 还是 假的？瑞普生物回复：投资者您好，上述相关消息不属实，公司目前无该款产品，相关领域处于研发布局阶段，请以官方公告为准。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900021725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK0239","BK0046","BK0070","300119"],"gpt_icon":0},{"id":"2588725707","title":"瑞普生物（300119）披露召开2025年第六次临时股东会通知，12月1日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588725707","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588725707?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:55","pubTimestamp":1764582928,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，瑞普生物报收于19.83元，较前一交易日下跌0.1%，最新总市值为92.16亿元。该股当日开盘19.85元，最高19.91元，最低19.75元，成交额达5686.71万元，换手率为0.86%。近日，瑞普生物发布公告称，公司将于2025年12月15日召开2025年第六次临时股东会，会议采取现场与网络投票相结合的方式进行，股权登记日为2025年12月8日。公告还指出，中小投资者的表决情况将单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100023679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","BK0239","300119"],"gpt_icon":0},{"id":"2586359587","title":"瑞普生物：董事会换届选举","url":"https://stock-news.laohu8.com/highlight/detail?id=2586359587","media":"证券日报 ","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586359587?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:10","pubTimestamp":1764339000,"startTime":"0","endTime":"0","summary":"证券日报网讯 11月28日晚间，瑞普生物发布公告称，公司于2025年11月28日召开第五届董事会第三十次（临时）会议，审议通过了《关于公司董事会换届选举暨提名第六届董事会非独立董事候选人的议案》《关于公司董事会换届选举暨提名第六届董事会独立董事候选人的议案》，董事会提名第六届董事会非独立董事候选人5人：李守军先生、徐雷先生、刘爱玲女士、朱秀同先生、李睿女士；提名独立董事候选人3人：董义春先生、王凯先生、李娅女士。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-28/doc-infyypay7168191.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-28/doc-infyypay7168191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","BK0046","300119","BK0239"],"gpt_icon":0},{"id":"2586382226","title":"瑞普生物（300119）披露取得新兽药注册证书，11月27日股价上涨1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586382226","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586382226?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:35","pubTimestamp":1764254124,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，瑞普生物报收于19.87元，较前一交易日上涨1.07%，最新总市值为92.35亿元。该股当日开盘19.74元，最高20.1元，最低19.62元，成交额达8958.19万元，换手率为1.34%。公司于近日发布公告称，瑞普生物股份有限公司及下属公司近日获得农业农村部核发的猫鼻气管炎、杯状病毒病、泛白细胞减少症三联灭活疫苗新兽药注册证书。产品上市前尚需取得兽药产品批准文号，公司正推进相关申请工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","300119","BK0239"],"gpt_icon":0},{"id":"2586443383","title":"瑞普生物：现有H5+H7疫苗含H5N5毒株成分","url":"https://stock-news.laohu8.com/highlight/detail?id=2586443383","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586443383?lang=zh_cn&edition=full","pubTime":"2025-11-25 11:33","pubTimestamp":1764041601,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物11月25日在投资者关系平台上答复投资者关心的问题。投资者提问：国外部分地区暴发H5N5禽流感且首次出现人感染并致死案例，请公司是否有H5N5禽流感疫苗？瑞普生物回复：投资者您好，公司及国内目前均无H5N5禽流感专用疫苗，国外流行的H5N5毒株属clade2.3.4.4b基因分支，疫苗保护效果评估核心看基因分支而非血清型，公司现有的H5+H7疫苗含该分支毒株成分，理论上可提供较好保护。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500012896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300119","BK0046","159646"],"gpt_icon":0},{"id":"2585183841","title":"瑞普生物：截至2025年11月20日股东总户数2.5万余户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585183841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585183841?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:12","pubTimestamp":1763712730,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至11月20日，公司持股股东人数多少人？谢谢瑞普生物回复：投资者您好，截至2025年11月20日，公司股东总户数2.5万余户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100019515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0046","300119"],"gpt_icon":0},{"id":"2582326118","title":"瑞普生物：截至2025年11月10日股东总户数2.5万余户","url":"https://stock-news.laohu8.com/highlight/detail?id=2582326118","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582326118?lang=zh_cn&edition=full","pubTime":"2025-11-12 16:45","pubTimestamp":1762937136,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：麻烦告知一下11月10号的股东人数瑞普生物回复：投资者您好，截至2025年11月10日，公司股东总户数2.5万余户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200026082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","300119","BK0239"],"gpt_icon":0},{"id":"2581270559","title":"股市必读：瑞普生物（300119）11月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2581270559","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581270559?lang=zh_cn&edition=full","pubTime":"2025-11-06 03:26","pubTimestamp":1762370809,"startTime":"0","endTime":"0","summary":"截至2025年11月5日收盘，瑞普生物报收于20.42元，上涨0.0%，换手率1.42%，成交量4.76万手，成交额9744.76万元。董秘最新回复投资者： 请问瑞派宠物医院有单独上市计划，或者完整注入上市公司的计划吗？如有触及公司信息披露事项，公司将按照法律法规规定及时履行信息披露义务。交易信息汇总资金流向11月5日主力资金净流出101.75万元；游资资金净流入285.03万元；散户资金净流出183.27万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600003006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","BK0239","300119"],"gpt_icon":0},{"id":"2580227291","title":"瑞普生物：截至2025年10月31日股东户数约2.5万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580227291","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580227291?lang=zh_cn&edition=full","pubTime":"2025-11-04 11:33","pubTimestamp":1762227221,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止10月31日，公司股东人数多少？谢谢瑞普生物回复：投资者您好，截至2025年10月31日，公司股东总户数约2.5万户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400014550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300119","BK0070","BK0046","BK0239"],"gpt_icon":0},{"id":"2579165173","title":"瑞普生物：已拥有18项宠物新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2579165173","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579165173?lang=zh_cn&edition=full","pubTime":"2025-10-30 11:36","pubTimestamp":1761795365,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物10月30日在投资者关系平台上答复投资者关心的问题。公司深耕宠物医药领域多年，目前已拥有18项宠物新兽药注册证书，满足宠物医疗升级下从预防、诊断到治疗的多元化用药需求。瑞派宠物医院以专业服务提升产品价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000018514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300119","BK0070","BK0046"],"gpt_icon":0},{"id":"2579945179","title":"股市必读：瑞普生物（300119）10月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2579945179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579945179?lang=zh_cn&edition=full","pubTime":"2025-10-29 04:16","pubTimestamp":1761682577,"startTime":"0","endTime":"0","summary":"截至2025年10月28日收盘，瑞普生物报收于21.55元，上涨1.03%，换手率3.8%，成交量12.73万手，成交额2.75亿元。董秘最新回复投资者： 强烈希望贵司收购宠物用品和食品各一两家，实现全链路的宠物大集团梦想，凭借贵司强大供应链，和瑞派医院等等资源，真正做大成超越乖宝和中宠的集团董秘： 投资者您好，非常感谢您的宝贵建议！当日关注点来自交易信息汇总：10月28日主力资金净流入1503.57万元，显示主力对瑞普生物股票的积极介入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900007479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","300119","BK0239"],"gpt_icon":0},{"id":"2578654701","title":"股市必读：瑞普生物(300119)股东户数2.5万户，较上期减少3.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578654701","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578654701?lang=zh_cn&edition=full","pubTime":"2025-10-27 03:39","pubTimestamp":1761507550,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，瑞普生物报收于20.87元，下跌0.14%，换手率1.63%，成交量5.45万手，成交额1.14亿元。来自股本股东变化：截至2025年10月10日，公司股东户数环比下降3.85%，户均持股数量上升至1.86万股。股本股东变化股东户数变动截至2025年10月10日，公司股东户数为2.5万户，较9月19日减少1000户，减幅为3.85%。归属于上市公司股东的净利润单季度为1.06亿元，同比增长23.02%；前三季度累计为3.62亿元，同比增长45.64%。两项议案均获3票同意，0票反对，0票弃权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700000941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300119","BK0046","BK0070","BK0239"],"gpt_icon":0},{"id":"2577171085","title":"瑞普生物（300119）披露2025年三季度报告，10月24日股价下跌0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577171085","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577171085?lang=zh_cn&edition=full","pubTime":"2025-10-24 22:17","pubTimestamp":1761315465,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，瑞普生物报收于20.87元，较前一交易日下跌0.14%，最新总市值为96.99亿元。该股当日开盘20.83元，最高21.19元，最低20.74元，成交额达1.14亿元，换手率为1.63%。近日，瑞普生物发布2025年第三季度报告。公告显示，公司2025年第三季度实现营业收入836,737,374.53元，同比增长1.44%；前三季度累计营业收入为2,544,325,031.33元，同比增长13.50%。归属于上市公司股东的净利润方面，第三季度为105,784,584.02元，同比增长23.02%；前三季度累计为362,307,052.90元，同比增长45.64%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400042716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0046","300119"],"gpt_icon":0},{"id":"2577659678","title":"瑞普生物(300119.SZ)发布前三季度业绩，归母净利润3.62亿元，增长45.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577659678","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577659678?lang=zh_cn&edition=full","pubTime":"2025-10-24 17:08","pubTimestamp":1761296921,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞普生物(300119.SZ)发布2025年三季度报告，该公司前三季度营业收入为25.44亿元，同比增长13.50%。归属于上市公司股东的净利润为3.62亿元，同比增长45.64%。归属于上市公司股东的扣除非经常性损益的净利润为2.69亿元，同比增长24.92%。基本每股收益为0.7972元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑞普生物(300119.SZ)发布前三季度业绩，归母净利润3.62亿元，增长45.64%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300119"],"gpt_icon":0},{"id":"2577634139","title":"瑞普生物：截至2025年10月20日股东总户数约2.5万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2577634139","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577634139?lang=zh_cn&edition=full","pubTime":"2025-10-23 08:55","pubTimestamp":1761180908,"startTime":"0","endTime":"0","summary":"证券之星消息，瑞普生物(300119)10月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止至2025年10月20日，公司股东人数总数是多少?谢谢!瑞普生物回复：投资者您好，截至2025年10月20日，公司股东总户数约2.5万户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300006374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300119","BK0070","BK0046","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766773554820,"stockEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0745},{"period":"6month","weight":0.0089},{"period":"1year","weight":0.0749},{"period":"ytd","weight":0.0662}],"compareEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.1575},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.1826}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"瑞普生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"25000人(较上一季度增加0.00%)","perCapita":"13398股","listingDate":"2010-09-17","address":"天津市东丽区自贸试验区(空港经济区)东九道1号","registeredCapital":"46475万元","survey":"　　瑞普生物股份有限公司的主营业务是兽用生物制品、兽用药物制剂（化学药品、中兽药、消毒剂等）、兽用原料药、兽用功能性添加剂的研发、生产、销售及提供动物疫病整体防治解决方案。公司的主要产品是禽元、优瑞康泰、信法泰、双欣立克、必立清、坦布舒、立本康、康替优、瑞泰净、诸传雄、维乐复康、诸连富、文易舒、倍扶欣、替米佳、依诺佳、瑞必泰、扬极安、必服康、倍汝宁、瑞典康、瑞喵舒、瑞可林、瑞美静、超比欣、莫普欣、菲比欣、妙普净、环舒宁、托曲珠利、头孢噻呋钠、盐酸沃尼妙林。","listedPrice":60},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞普生物(300119)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞普生物(300119)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞普生物,300119,瑞普生物股票,瑞普生物股票老虎,瑞普生物股票老虎国际,瑞普生物行情,瑞普生物股票行情,瑞普生物股价,瑞普生物股市,瑞普生物股票价格,瑞普生物股票交易,瑞普生物股票购买,瑞普生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞普生物(300119)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞普生物(300119)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}